BioSpace News Archive

Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in patients with narcolepsy, announced today that it will host a conference call and live webcast at 8:30 a.m. ET on Tuesday, March 9, 2021

Light therapy, also known as phototherapy, uses daylight or some equivalent form of light to treat a wide range of mental illnesses and skin disorders.

Growing utilization of medical X-ray machine to detect numerous health conditions such as bone fractures, infections, calcifications, tumors, arthritis, and others will augment medical X-ray market growth in the upcoming years.

Rise in demand for healthcare products at an affordable price point could spur the OTC drug market growth.

Growing funding in clinical research and development activities is projected to push the Parkinson’s disease therapeutics market growth over time.

OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE) today announced that Alexis Peyroles, Chief Executive Officer, will provide an overview of the Company’s business at the upcoming H.C. Wainwright Global Life Sciences Conference to be held March 9-11, 2021.

Novamind Inc., a leading mental health company specialized in psychedelic medicine, is pleased to announce its participation in the Benzinga Cannabis Capital Conference, on February 25th and 26th, 2021, one of the select companies to be featured from the emerging psychedelics industry.

Perrigo Company plc, a leading global provider of Quality, Affordable Self-Care Products, announced that its Board of Directors approved a 7% increase in the Company’s quarterly dividend to $0.24 per share from $0.225 per share.

Arist, developers of an innovative enterprise-level text messaging platform for education, training and outreach, has announced that its technology has been optimized to better meet the needs of the life sciences industry.

National Spine and Pain Centers, the nation’s leading network of interventional pain practices, announced that Douglas P. Badertscher has joined its leadership team as administrative President.